发明申请
- 专利标题： Use of ribose in first response to acute myocardial infarction
- 专利标题（中）： 使用核糖首先应对急性心肌梗死
-
申请号： US12384282申请日： 2009-04-02
-
公开(公告)号： US20100055206A1公开(公告)日： 2010-03-04
- 发明人: John A. St. Cyr , David J. Perkowski
- 申请人： John A. St. Cyr , David J. Perkowski
- 主分类号： A61K31/7004
- IPC分类号： A61K31/7004 ; A61P9/04 ; A61K33/00
摘要：
D-ribose is administered to patients suffering an acute myocardial infarction during first response care, in order to prevent cardiac compromise. In those patients able to ingest fluids, two to five grams of D-ribose is administered orally. In a patients unable to ingest fluids, or in a patient with and intravenous line, pyrogen-free D-ribose is administered intravenously at a rate of 50-300 mg/kg/hour.
信息查询
